BIOMAT Database Logo BIOMAT Database Logo

Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. 1994

P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Centro di Endocrinologia ed Oncologia Sperimentale, CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy.

Insulin-like growth factor II (IGF-II) is a mitogen for many cell types and an important modulator of muscle growth and differentiation. IGF-II gene is prevalently expressed during prenatal development and its gene activity is regulated by genomic imprinting, in that the allele inherited from the father is active and the allele inherited from the mother is inactive in most normal tissues. IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor. Here we show that monoallelic expression of IGF-II gene is conserved in normal adult muscle tissue whereas two or more copies of active IGF-II alleles, arising by either relaxation of imprinting or duplication of the active allele, are found in 9 out of 11 (82%) rhabdomyosarcomas retaining heterozygosity at 11p15, regardless of the histological subtype. Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis. Among different types of muscle tumors, relaxation of imprinting seems to arise prevalently in rhabdomyosarcomas, since we have detected only one case of partial reactivation of the maternal IGF-II allele out of 7 leiomyosarcomas tested.

UI MeSH Term Description Entries
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Insulin-like growth factor gene expression in human smooth muscle tumors.
October 1990, Cancer research,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Expression and CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors.
December 1992, Cancer research,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Insulin-like growth factor II gene expression in human neuroblastoma.
January 1991, Progress in clinical and biological research,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis.
April 1989, Proceedings of the National Academy of Sciences of the United States of America,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene.
October 1998, Biochemical and biophysical research communications,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors.
September 1990, International journal of cancer,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors.
January 1997, Oncology,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Gene expression of insulin-like growth factor II in human intracranial meningioma.
December 1993, Cancer,
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver.
July 1998, Hepatology (Baltimore, Md.),
P V Pedone, and R Tirabosco, and A O Cavazzana, and P Ungaro, and G Basso, and R Luksch, and M Carli, and C B Bruni, and R Frunzio, and A Riccio
Insulin-like growth factor II regulation of gene expression in rat and human hepatomas.
January 1995, Journal of cellular physiology,
Copied contents to your clipboard!